Gender-Biased Nuclear Medicine
Radioiodine therapy is essentially contra-indicated in patients who are known to be pregnant. Radioiodine easily crosses the placenta and the foetal thyroid begins to accumulate iodine at about 10 weeks of gestational age. If radioiodine treatment of thyroid carcinoma is to be performed, it should be delayed until after delivery. If this is done, the physician should also be aware that radioiodine is excreted in breast milk and breast-feeding should be stopped completely after a therapeutic dose. If this is not done the infant may become permanently hypothyroid or be at high risk for subsequent thyroid cancer.This session will discuss about the health concern of women exposed to radiation therapy, especially during the months of pregnancy, topics of discussion will include Gender Biases in Diseases, Pregnancy and Harmful effects of Radiation, Women with Ischemic Heart Disease, Osteoporosis, Gynecologic and Breast Oncologic Imaging, Radiation dose concerns for pregnant and lactating patients.
- Gender Biases in Diseases
- Pregnancy and Harmful Effects of Radiation
- Women With Ischemic Heart Disease
- Osteoporosis
- Gynecologic and Breast Oncologic Imaging
Related Conference of Gender-Biased Nuclear Medicine
Cancer Diagnostics Conference Expo
14th World Congress on Cancer Therapy
Quality and Safety in Nuclear Medicine Molecular Imaging Meeting
Advances in Cancer Immunotherapy Conference
Breast MR Imaging Conference
10th Interventional Radiology Conference
Imaging in Israel
Nuclear Science Symposium Nuclear Imaging Conference
3rd International Conference on Bioimaging
29th Annual Congress of European Association of Nuclear Medicine
4th Pediatric Oncology Conference
Asian Oncology Summit
European Molecular Imaging Meeting
European Congress on Head Neck Oncology
Gender-Biased Nuclear Medicine Conference Speakers
Recommended Sessions
- Advanced Nuclear Medicine Equipments
- Advances in Cancer Detection and Imaging
- Bioimaging
- Case Reports
- Clinical Nuclear Medicine
- Diagnostic Imaging
- Entrepreneurs Investment Meet
- Gender-Biased Nuclear Medicine
- Interventional Radiology
- Nuclear Magnetic Resonance Imaging
- Nuclear Medicine
- Radiation Oncology
- Radiation Therapy
- Radiation Therapy Courses & Career
- Radiography
- Radiology & Medical Imaging
- Radiopharmaceuticals
- Side Effects of Nuclear Medicine
- Therapeutic Nuclear Medicine
Related Journals
Are you interested in
- Advances in Cancer Detection - RADIOCANCER 2025 (France)
- Advances in Imaging - RADIOCANCER 2025 (France)
- Artificial intelligence - RADIOCANCER 2025 (France)
- Breast Radiography - RADIOCANCER 2025 (France)
- Cardiac Imaging - RADIOCANCER 2025 (France)
- Clinical Research - RADIOCANCER 2025 (France)
- Industrial Forum: Radiology - RADIOCANCER 2025 (France)
- Magnetic Resonance Imaging - RADIOCANCER 2025 (France)
- Magnetic Resonance Imaging - RADIOCANCER 2025 (France)
- Mammography - RADIOCANCER 2025 (France)
- Medical Imaging - RADIOCANCER 2025 (France)
- Nuclear Medicine - RADIOCANCER 2025 (France)
- PET/MRI versus PET/CT Hybrid - RADIOCANCER 2025 (France)
- Radiation Oncology & Cancer - RADIOCANCER 2025 (France)
- Radiographic Testing - RADIOCANCER 2025 (France)
- Radiography - RADIOCANCER 2025 (France)
- Radiology Trends and Technology - RADIOCANCER 2025 (France)
- Radiology Trends and Technology - RADIOCANCER 2025 (France)
- Ultrasound - RADIOCANCER 2025 (France)